US Patent Litigations are now available. Check here

IP Verse

Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters

PatentPatent Analysis

EP2234617

JANSSEN PHARMACEUTICA
Application Number
EP08863534A
Filing Date
Dec 17, 2008
Status
Patent Maintained As Amended
Oct 3, 2024
Grant Date
Nov 6, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4005555B1
EP4025188B1
EP4025187B1

Biblio Summary

The patent EP2234617B2 was granted on Nov 6, 2024 by Janssen Pharmaceutica The patent is currently Patent Maintained As Amended.

Patents Cited during Opposition New

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS5254556
 N/A
OppositionUS6077843
 N/A
OppositionUS6555544
 N/A
OppositionWO2006114384
 N/A
OppositionUS20070014918P
P1 00000000
OppositionUS20080120276P
P2 00000000
OppositionWO9925354
 N/A
OppositionUS2007197591
 N/A
OppositionWO9744039
 N/A
OppositionEP0904081
 N/A
OppositionEP1033987
 N/A
OppositionWO2009080651
 N/A
OppositionWO2004018312
 N/A
OppositionUS2006079846
 N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents